This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hatfield, GB (2016)
- Hertfordshire, GB (2018)
Company Filing History:
Years Active: 2016-2018
Title: Alan James Braunton: Innovator in Neurological Treatments
Introduction
Alan James Braunton is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurological disorders. With a total of 3 patents, his work focuses on innovative solutions that may improve cognitive function in patients suffering from conditions such as Alzheimer-type dementia and dementia with Lewy bodies.
Latest Patents
Braunton's latest patents include the development of 4-azaindole derivatives. These compounds serve as modulators of the muscarinic acetylcholine receptor (mAChR) M1. They hold promise for the prevention, disease modification, or symptomatic treatment of cognitive deficits associated with neurological disorders. His work emphasizes the potential of these derivatives in creating effective pharmaceutical compositions aimed at enhancing cognitive health.
Career Highlights
Alan James Braunton is currently associated with Eisai R&D Management Co., Ltd. His role in this organization allows him to leverage his expertise in pharmaceutical research and development. His innovative approach has positioned him as a key player in the quest for effective treatments for cognitive impairments.
Collaborations
Throughout his career, Braunton has collaborated with notable colleagues, including Andrew Payne and Jose Luis Castro Pineiro. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Alan James Braunton's contributions to the field of neurological treatments through his innovative patents and collaborations highlight his commitment to improving cognitive health. His work continues to pave the way for advancements in the treatment of debilitating neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile